Biogen
Phone: +1 781-464-2000
| Formerly | Biogen Idec Inc. (2003–2015) |
|---|---|
| Type | Public company |
| Traded as |
|
| Industry | Biotechnology |
| Founded | 1978 (1978) |
| Founders | Kenneth Murray Phillip Allen Sharp Walter Gilbert Heinz Schaller Charles Weissmann |
| Headquarters | Cambridge, Massachusetts, U.S. |
| Key people | Stelios Papadopoulos (Chairman) Michel Vounatsos (CEO) |
| Products | Avonex, Fampyra, Plegridy, Tecfidera, Tysabri, Spinraza |
| Revenue |  US$10.981 billion (2021) |
| Operating income | US$2.84 billion (2021) |
| Net income | US$1.727 billion (2021) |
| Total assets | US$23.877 billion (2021) |
| Total equity |  US$10.96 billion (2021) |
| Number of employees | 9,100 (2020) |
| Website | biogen.com |
At Biogen, our mission is clear: we are pioneers in neuroscience. Since our founding in 1978 as one of the world’s first global biotechnology companies, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
For detailed contact information visit location pages below.
Biogen's locations around the world
Europe
North America
Oceania
Clinical Trials sponsored by Biogen
-
Biogen아직 모집하지 않음
-
Biogen모병
-
Biogen모병원발성 막성 신증호주, 대만, 중국, 미국, 일본, 아르헨티나, 브라질, 말레이시아, 인도, 대한민국
-
Biogen모집하지 않고 적극적으로척추 근육 위축미국, 헝가리, 일본, 이탈리아, 독일
-
Biogen초대로 등록아급성 피부 홍반성 루푸스 | 만성 피부 홍반성 루푸스미국, 브라질, 스페인, 대만, 캐나다, 프랑스, 독일, 일본, 이탈리아, 콜롬비아, 영국, 세르비아, 칠레, 필리핀 제도, 불가리아, 중국, 스웨덴, 스위스, 멕시코, 대한민국, 아르헨티나, 헝가리, 슬로바키아, 폴란드, 포르투갈